Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

Combing a weight-loss drug and hormone therapy may be the key to shedding pounds.

Preclinical study shows oral PL7737 agonist outperforms tirzepatide alone in rodent models, supporting Palatin’s plans for ...

For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss.

Discover how Semaglutide helped me lose 120 pounds and transform my life. A personal, honest look at the ups, downs, and what really worked.

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...

The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health ...

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...

Presented by AstraZeneca{beacon} Health Care Health Care   The Big Story CMS targets hospitals with site-neutral drug ruleThe ...

Roughly 16 million American adults are taking GLP-1 medications. They are a major breakthrough for people to shed pounds and ...

For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...